FITXR
23.3.2023 14:01:34 CET | Business Wire | Press release
FitXR is continuing to expand its popular virtual reality (VR) fitness offering with the UK, EU and Asia markets by launching on the popular PICO VR headsets. FitXR’s launch on PICO represents its commitment to make VR fitness accessible to all, irrespective of the user’s preference in hardware choice. As the mass market appeal in VR continues to grow, it will bring with it increased interest in hardware developers, innovation and consumer choice and in turn the desirability in multi-platform offerings like FitXR.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230323005314/en/
(Photo: Business Wire)
In January 2023, FitXR launched two new studio offerings: Sculpt and Combat, to add to its already robust suite of offerings that include High Intensity Interval Training (HIIT), Dance and Box workout options. The launch of Sculpt (workouts inspired by barre, pilates, and isometric strength training) and Combat (workouts inspired by karate, muay thai and taekwondo) support FitXR’s continued mission to provide the widest variety of workout experiences available in the metaverse today.
FitXR is now reaching new audiences by bringing its at-home virtual fitness experience to PICO headsets. Starting today, any consumer who downloads FitXR onto their PICO 4 or PICO Neo Link 3 headset will get 30 days free membership; an offer running until the 30th of April.
“Launching on PICO is a pivotal moment for FitXR,” said Sam Cole, CEO and Co-founder of FitXR. “We already offer the most diverse and unique fitness experience, and by expanding to the new PICO headset, we’re furthering our aim to provide this to every person, in every household, in every geography, and on any hardware device. It also reinforces our position as the leading global VR Fitness app with members around the world.”
“For PICO, launching FitXR as a subscription app on our platform underlines our commitment to bring the widest variety of high quality and customizable fitness experiences to our customers,” said Peter Li, Head of Gaming Partnerships at PICO.
FitXR’s launch on PICO is also indicative of the heightened appetite for combining technology and gaming to provide the optimal fitness experience. On FitXR, users can access different fitness studios whilst customising these experiences to meet their goals. Every time members enter the app, they can choose exactly how they want to work out; by studio type, music genre, intensity level, and/or time duration and then choose from one of many fully immersive 3D workout environments. Members can Dance or Box on a downtown city building rooftop, take Sculpt classes on the beachfront seaside or fight and defend in an outdoor martial arts-inspired Combat arena - all while punching flying fireballs, earning points and extending their winning streak.
“We never forget to bring the fun. The fun matters just as much as the results,” said Lisa Raggiri, Chief Marketing Officer at FitXR. “Whilst all of our classes are choreographed by certified fitness instructors to ensure results, we are strong believers in leveraging the unique immersive nature of VR to provide a fun escape. We know that by jumping into a fully immersive workout, our members have greater enjoyment, improve their consistency and see real results.”
In case variety, customization, gamification and numerous 3D environments wasn’t enough, FitXR is launching its first Box Training Program created in partnership with Olympic Boxing Champion Nicola Adams.
Says Nicola: “I am so excited to be able to finally share that I’ve been working closely alongside FitXR on this new boxing starter program, Box Like a Pro. We’ve broken it down and will delve into the principles of boxing – whether you’re looking to work on the perfect stance or refining your uppercut, this program is one for all. Regardless of your level, this program provides both beginners and intermediate boxers with the foundations and technical skills to build on and succeed. Having begun boxing at a young age, it’s been vital in helping build up my confidence and I hope users step away from this program feeling stronger and more energized, both mentally and physically. My hope is that I can inspire people to get more active, build and maintain a healthy lifestyle and show that fitness can be fun! I love spending weekends gaming, so I’ve enjoyed being able to blend it into fitness with FitXR. It’s been inspiring to partner with FitXR who have made transformative strides in elevating fitness for the better and making it more inclusive for all.”
About FitXR:
FitXR merges immersive VR with total body workouts designed by top fitness experts. Dedicated to making fitness more fun and accessible for everyone, FitXR offers classes within five distinct workout studios - Box, Dance, HIIT, Sculpt and Combat. FitXR provides a truly engaging, multiplayer experience along with constantly refreshed classes, environments and music. FitXR is available on Meta Quest 2.
About PICO:
Founded in March 2015, PICO is a leading VR company with independent innovation and R&D capabilities, focusing on VR all-in-one technology. Embracing a mission to bridge connections, enrich life, and release infinity, PICO is committed to building an integrated XR platform that inspires the community and empowers developers, creators, and businesses. To learn more, visit picoxr.com or business.picoxr.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230323005314/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom